Trial Profile
A 30 week, forced titration and randomised, crossover, multicentre, multinational trial to evaluate the efficacy and safety of rosuvastatin and atorvastatin in subjects with homozygous familial hypercholesterolemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Sep 2008
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Hyperlipoproteinaemia type II
- Focus Therapeutic Use
- 27 Mar 2006 New trial record.